CY1107666T1 - Διαδικασια για την παρασκευη συνθεσεων γοναδοτροπινης - Google Patents

Διαδικασια για την παρασκευη συνθεσεων γοναδοτροπινης

Info

Publication number
CY1107666T1
CY1107666T1 CY20071100763T CY071100763T CY1107666T1 CY 1107666 T1 CY1107666 T1 CY 1107666T1 CY 20071100763 T CY20071100763 T CY 20071100763T CY 071100763 T CY071100763 T CY 071100763T CY 1107666 T1 CY1107666 T1 CY 1107666T1
Authority
CY
Cyprus
Prior art keywords
gonadotropins
menotropins
follitropin
fsh
protein
Prior art date
Application number
CY20071100763T
Other languages
English (en)
Inventor
Band Claudio Fernando Wolfenson
Liliana Ester Balanian
José Felipe GROISMAN
Erundina Marta Fasanella
Original Assignee
Instituto Massone S.A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto Massone S.A filed Critical Instituto Massone S.A
Publication of CY1107666T1 publication Critical patent/CY1107666T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Διαδικασία καθαρισμού ανθρώπινων ουρικών γοναδοτροπινών υψηλής βιολογικής δραστικότητας και χημικής καθαρότητας απολύτως απαλλαγμένων από ξένα μολυντικά υλικά προερχόμενα από τη χρήση βιολογικών αντιδραστηρίων ή χρωστικών χρωματογραφίας, από ακατέργαστο δείγμα γοναδοτροπινών. Η υψηλής βιολογικής δραστικότητας και χημικώς καθαρή σύνθεση ανθρώπινων γοναδοτροπινών η οποία ελήφθη μέσω αυτής της διαδικασίας, χρησιμοποιούνται για την αντιμετώπιση της υπογονιμότητας και επιλέγονται από την ομάδα της φολλιτροπίνης ή των μενοτροπινών, έχοντας μια βιοδραστικότητα μεγαλύτερη από 2500 IU/ mg πρωτεΐνης όπως ελέγχθηκε μέσω βιολογικού προσδιορισμού σε αρουραίους, για αμφότερες τις FSH και LH ορμόνες για μενοτροπίνες και μεγαλύτερη από 5000 lU/mg πρωτεΐνης για φολλιτροπίνη έχοντας μια GSH:LH αναλογία περίπου 75:1 Φαρμακευτικά παρασκευάσματα των εν λόγω γοναδοτροπινών απαλλαγμένα από αυτά τα μολυντικά υλικά επίσης περιλαμβάνονται εντός της παρούσας εφεύρεσης.
CY20071100763T 1999-04-16 2007-06-11 Διαδικασια για την παρασκευη συνθεσεων γοναδοτροπινης CY1107666T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12954099P 1999-04-16 1999-04-16
EP00926922A EP1169349B1 (en) 1999-04-16 2000-04-14 Process for preparing gonadotropin compositions

Publications (1)

Publication Number Publication Date
CY1107666T1 true CY1107666T1 (el) 2013-04-18

Family

ID=22440494

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100763T CY1107666T1 (el) 1999-04-16 2007-06-11 Διαδικασια για την παρασκευη συνθεσεων γοναδοτροπινης

Country Status (13)

Country Link
EP (1) EP1169349B1 (el)
JP (1) JP4574865B2 (el)
AT (1) ATE358139T1 (el)
AU (1) AU779005B2 (el)
BR (1) BRPI0010677B8 (el)
CA (1) CA2370225C (el)
CY (1) CY1107666T1 (el)
DE (1) DE60034117T2 (el)
DK (1) DK1169349T3 (el)
ES (1) ES2284494T3 (el)
MX (1) MXPA01010522A (el)
PT (1) PT1169349E (el)
WO (1) WO2000063248A2 (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004023757D1 (de) * 2003-12-22 2009-12-03 Ares Trading Sa Methode zur reinigung von fsh
UA87709C2 (ru) * 2004-11-09 2009-08-10 Эйрэс Трейдинг С.А. Способ очищения фолликулостимулирующего гормона
EP1809663B1 (en) * 2004-11-09 2008-09-17 Ares Trading S.A. Method for purifying fsh
HUE038947T2 (hu) 2005-08-26 2018-12-28 Ares Trading Sa Eljárás glikozilált béta-interferon elõállítására
WO2007065918A2 (en) * 2005-12-09 2007-06-14 Ares Trading S.A. Method for purifying fsh or a fsh mutant
RS52976B (en) 2007-06-28 2014-02-28 Biogenerix Ag Cell clone produced by FSH
DE202009009905U1 (de) 2008-02-08 2009-10-29 Biogenerix Ag Flüssig-Formulierung von FSH
CN101269215B (zh) * 2008-05-15 2011-03-23 上海天伟生物制药有限公司 一种糖蛋白激素组合物
UA106369C2 (ru) * 2009-04-01 2014-08-26 Рациофарм Гмбх Способ очистки рекомбинантного фсг
EP2325194A1 (en) 2009-11-24 2011-05-25 Glycotope GmbH Process for the purification of glycoproteins
CN103159846B (zh) * 2013-04-09 2015-04-22 邹平县滨渤生物科技有限公司 Hmg粗品的制备方法
WO2015177751A1 (en) 2014-05-23 2015-11-26 Instituto Massone S.A. A process for obtaining hmg-up (human menopausal gonadotropin with ultra-purity grade) and a composition free of contaminants
JP7163027B2 (ja) 2015-02-26 2022-10-31 フェリング ベスローテン フェンノートシャップ 不妊症の処置方法
CN108070640B (zh) * 2018-01-12 2021-09-21 浙江省农业科学院 一种与卵泡刺激素剂量呈线性相关的基因的筛选方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3819M (fr) * 1963-03-11 1966-01-10 Serono Ist Farm Nouvelle hormone hypophysaire a activité différenciée.
IT1287138B1 (it) * 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh

Also Published As

Publication number Publication date
WO2000063248A2 (en) 2000-10-26
AU4549100A (en) 2000-11-02
EP1169349B1 (en) 2007-03-28
ATE358139T1 (de) 2007-04-15
BR0010677A (pt) 2002-02-05
BR0010677B1 (pt) 2013-04-30
AU779005B2 (en) 2004-12-23
MXPA01010522A (es) 2003-08-19
CA2370225C (en) 2010-06-29
PT1169349E (pt) 2007-06-18
JP2002542260A (ja) 2002-12-10
EP1169349A2 (en) 2002-01-09
WO2000063248A3 (en) 2001-02-01
DE60034117D1 (de) 2007-05-10
ES2284494T3 (es) 2007-11-16
DK1169349T3 (da) 2007-07-30
JP4574865B2 (ja) 2010-11-04
CA2370225A1 (en) 2000-10-26
BRPI0010677B8 (pt) 2021-05-25
DE60034117T2 (de) 2007-12-13

Similar Documents

Publication Publication Date Title
CY1107666T1 (el) Διαδικασια για την παρασκευη συνθεσεων γοναδοτροπινης
Nguyen et al. Butelase-mediated cyclization and ligation of peptides and proteins
Al-Obeidi et al. Potent and prolonged-acting cyclic lactam analogs of. alpha.-melanotropin: design based on molecular dynamics
DE69833751T2 (de) IN POSITION 5 UND 6 MODIFIZIERTE GONADOTROPIN FREISETZENDES HORMON (GnRH)-ANTAGONISTEN
JP2002530059A (ja) 輸送ベクター
JPH0532696A (ja) 副甲状腺ホルモン誘導体
BR0207576A (pt) Variante glicosilada de um polipeptìdeo de interferon beta precursor (ifnb), processos de aumentar a glicosilação in vivo de uma molécula de ifnb precursora, de produzir uma molécula de ifnb glicosilada, para preparar uma variante conjugada e de tratar um mamìfero com esclerose múltiplam composição farmacêutica, molécula de ifnb variante, sequência de nucleotìdeo, vetor de expressão, célula hospedeira de glicosilação conjugado, e, uso de um conjugado
JP2002519392A (ja) 配送システム
EP0502198B1 (en) Novel polypeptide and anti-hiv drug prepared therefrom
JPH05503505A (ja) 高分子量ヒト血管形成因子
Schrimsher et al. Characterization of human and mouse granulocyte-macrophage-colony-stimulating factors derived from Escherichia coli
HUP0302099A2 (hu) Az azithromicin monohidrátja, eljárás az előállítására és a monohidrátot tartalmazó gyógyszerkészítmény
Takao et al. Chemical characterization of recombinant human leukocyte interferon A using fast atom bombardment mass spectrometry.
Spetzler et al. A novel strategy for the synthesis of the cysteine‐rich protective antigen of the malaria merozoite surface protein (MSP‐1) Knowledge‐based strategy for disulfide formation
AU2003267551A1 (en) Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
BR0211991A (pt) HormÈnio do crescimento humano modificado
Büllesbach et al. Relaxin structure. Quasi allosteric effect of the NH2-terminal A-chain helix.
CZ20011700A3 (cs) Benzoxazolové deriváty a léčiva na jejich bázi
DK292584D0 (da) Biologisk aktive konjugater, deres fremstilling og anvendelse
Ghosh et al. A novel method for sequence independent incorporation of activated/protected cysteine in Fmoc solid phase peptide synthesis
Vasileiou et al. Synthesis of the proteinase inhibitor LEKTI domain 6 by the fragment condensation method and regioselective disulfide bond formation
EP0364942B1 (de) Neue Isohirudine
Seon et al. Comparative Chemical Study of α-and µ-Chains from a Single Patient (SC)
Arnold et al. Improved solid-phase synthesis of the luteinizing-hormone releasing-hormone/follicle-stimulating hormone releasing-hormone (LH-RH/FSH-RH)
Krois Organisch-chemische Methoden